Literature DB >> 24777260

Stereotactic microdebrider in deep lateral orbital decompression for patients with thyroid eye disease.

John Nguyen1, Aaron Fay, Prashant Yadav, Peter W MacIntosh, Ralph Metson.   

Abstract

PURPOSE: Stereotactic navigation systems have been used in neurosurgery and otolaryngology with great success. The current investigation illustrates the novel use of a microdebrider with built-in stereotactic guidance in a series of thyroid orbitopathy patients who underwent deep lateral orbital wall decompression surgery.
METHODS: A noncomparative, interventional, retrospective case series of patients who underwent deep lateral deep orbital wall decompression from 2006 to 2013 was conducted in accordance with Institutional Review Board policy and the Declaration of Helsinki. Patient demographics, indications for surgery, pre-, intra-, and postoperative findings along with complications were recorded.
RESULTS: One hundred eight deep lateral orbital decompression surgeries were performed in 69 patients using the Straightshot M4 Microdebrider with built-in stereotactic guidance (Medtronics). Seventy-eight cases were in women and 30 cases were in men. The average age was 50.4 years (SD = 11.9 years). Indications for surgery included proptosis, exposure keratopathy, or compressive optic neuropathy. No patient experienced intraoperative complications. Specifically, cerebrospinal fluid leak, visual loss, infection, or unanticipated inflammation were not encountered. The average postoperative follow-up time was 5.35 months. Mean reduction in proptosis was 3.72 mm (SD = 2.1). Visual acuity improved in 32.4% (35/108) of cases.
CONCLUSIONS: This surgical instrument combines a single handpiece locator, microdebrider, irrigator, retractor, and suction device into one. It enhances anatomical localization during orbital decompression and, with an integrated tissue guard, may decrease the risk of injury to orbital soft tissues. Stereotactic navigation enhances the surgeon's ability to determine the maximal limits of decompression in real time by confirming depth of bone removal and may potentially increase surgeons' confidence in orbital decompression surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24777260     DOI: 10.1097/IOP.0000000000000132

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  7 in total

Review 1.  Orbital wall decompression in the management of Graves' orbitopathy: a systematic review with meta-analysis.

Authors:  Federico Maria Gioacchini; Shaniko Kaleci; Ettore Cassandro; Alfonso Scarpa; Michele Tulli; Claudia Cassandro; Massimo Ralli; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-18       Impact factor: 2.503

2.  Office-based endoscopic revision using a microdebrider for failed endoscopic dacryocystorhinostomy.

Authors:  Jongyeop Park; Hochang Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-24       Impact factor: 2.503

3.  Factors Predicting the Success of Combined Orbital Decompression and Strabismus Surgery in Thyroid-Associated Orbitopathy.

Authors:  Meng-Wei Hsieh; Chih-Kang Hsu; Pao-Cheng Kuo; Hsu-Chieh Chang; Yi-Hao Chen; Ke-Hung Chien
Journal:  J Pers Med       Date:  2022-01-31

Review 4.  Orbital decompression for thyroid eye disease: methods, outcomes, and complications.

Authors:  J M Jefferis; R K Jones; Z I Currie; J H Tan; S M Salvi
Journal:  Eye (Lond)       Date:  2017-12-15       Impact factor: 3.775

Review 5.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

6.  Anatomic Factors Predicting Postoperative Strabismus in Orbital Wall Fracture Repair.

Authors:  Chih-Kang Hsu; Meng-Wei Hsieh; Hsu-Chieh Chang; Ming-Cheng Tai; Ke-Hung Chien
Journal:  Sci Rep       Date:  2019-10-15       Impact factor: 4.379

Review 7.  Strategies in Surgical Decompression for Thyroid Eye Disease.

Authors:  Anny M S Cheng; Yi-Hsuan Wei; Shu-Lang Liao
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.